Applied DNA Sciences Inc (APDN)
0.183
-0.01
(-6.78%)
USD |
NASDAQ |
Nov 04, 16:00
0.1823
0.00 (0.00%)
Pre-Market: 08:51
Applied DNA Sciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -480.9% |
| December 31, 2023 | -124.0% |
| September 30, 2023 | -460.7% |
| June 30, 2023 | -106.3% |
| March 31, 2023 | 13.35% |
| December 31, 2022 | -73.03% |
| September 30, 2022 | -18.63% |
| June 30, 2022 | -26.17% |
| March 31, 2022 | -28.61% |
| December 31, 2021 | -113.3% |
| September 30, 2021 | -148.4% |
| June 30, 2021 | -202.8% |
| March 31, 2021 | -56.78% |
| December 31, 2020 | -297.6% |
| September 30, 2020 | -1.31K% |
| June 30, 2020 | -762.3% |
| March 31, 2020 | -534.3% |
| December 31, 2019 | -420.3% |
| September 30, 2019 | -73.18% |
| June 30, 2019 | -71.97% |
| March 31, 2019 | -345.1% |
| December 31, 2018 | -365.7% |
| September 30, 2018 | -290.7% |
| June 30, 2018 | -284.1% |
| March 31, 2018 | -205.6% |
| Date | Value |
|---|---|
| December 31, 2017 | -491.6% |
| September 30, 2017 | -249.2% |
| June 30, 2017 | -145.3% |
| March 31, 2017 | -378.7% |
| December 31, 2016 | -438.7% |
| September 30, 2016 | -147.6% |
| June 30, 2016 | -515.7% |
| March 31, 2016 | -604.8% |
| December 31, 2015 | -221.0% |
| September 30, 2015 | -12.46% |
| June 30, 2015 | -73.68% |
| March 31, 2015 | -124.2% |
| December 31, 2014 | -630.4% |
| September 30, 2014 | -326.2% |
| June 30, 2014 | -228.1% |
| March 31, 2014 | -431.7% |
| December 31, 2013 | -1.05K% |
| September 30, 2013 | -510.0% |
| June 30, 2013 | -331.2% |
| March 31, 2013 | -907.6% |
| December 31, 2012 | -2.74K% |
| September 30, 2012 | -607.7% |
| June 30, 2012 | -270.5% |
| March 31, 2012 | -297.8% |
| December 31, 2011 | -466.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.31K%
Minimum
Sep 2020
13.35%
Maximum
Mar 2023
-286.3%
Average
-136.2%
Median
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 3.20% |
| XWELL Inc | -21.50% |
| ProPhase Labs Inc | -248.7% |
| Veracyte Inc | 5.01% |
| OncoCyte Corp | -4.36K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -129.0% |
| Return on Assets | -55.87% |
| Return on Invested Capital | -129.0% |
| Gross Profit Margin (Quarterly) | 30.75% |
| Operating Margin (Quarterly) | -419.6% |
| Return on Net Operating Assets | -152.4% |